Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1.

J.S. Wijpkema; P.L. van Haelst; P.S. Monraats; M. Bruinenberg; A.H. Zwinderman; F. Zijlstra; G. van der Steege; R.J. de Winter; P.A.F.M. Doevendans; J. Waltenberger; J.W. Jukema; R.A. Tio

Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1.

Translated title of the contribution: Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1.

J.S. Wijpkema, P.L. van Haelst, P.S. Monraats, M. Bruinenberg, A.H. Zwinderman, F. Zijlstra, G. van der Steege, R.J. de Winter, P.A.F.M. Doevendans, J. Waltenberger, J.W. Jukema, R.A. Tio

Department of Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1.
Original language	Undefined/Unknown
Pages (from-to)	331-337
Number of pages	7
Journal	Pharmacogenetics and genomics
Volume	16
Issue number	5
Publication status	Published - 2006

Keywords

Econometric and Statistical Methods: General
Geneeskunde(GENK)
Bescherming en bevordering van de menselijke gezondheid
Other medical specialities

Cite this

Wijpkema, J. S., van Haelst, P. L., Monraats, P. S., Bruinenberg, M., Zwinderman, A. H., Zijlstra, F., van der Steege, G., de Winter, R. J., Doevendans, P. A. F. M., Waltenberger, J., Jukema, J. W., & Tio, R. A. (2006). Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1. Pharmacogenetics and genomics, 16(5), 331-337.

Wijpkema, J.S. ; van Haelst, P.L. ; Monraats, P.S. et al. / Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1. In: Pharmacogenetics and genomics. 2006 ; Vol. 16, No. 5. pp. 331-337.

@article{3599a1b65279449181ab5e1afc6b83f4,

title = "Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1.",

keywords = "Econometric and Statistical Methods: General, Geneeskunde(GENK), Bescherming en bevordering van de menselijke gezondheid, Other medical specialities",

author = "J.S. Wijpkema and {van Haelst}, P.L. and P.S. Monraats and M. Bruinenberg and A.H. Zwinderman and F. Zijlstra and {van der Steege}, G. and {de Winter}, R.J. and P.A.F.M. Doevendans and J. Waltenberger and J.W. Jukema and R.A. Tio",

year = "2006",

language = "Undefined/Unknown",

volume = "16",

pages = "331--337",

journal = "Pharmacogenetics and genomics",

issn = "1744-6872",

publisher = "Lippincott Williams & Wilkins",

number = "5",

}

Wijpkema, JS, van Haelst, PL, Monraats, PS, Bruinenberg, M, Zwinderman, AH, Zijlstra, F, van der Steege, G, de Winter, RJ, Doevendans, PAFM, Waltenberger, J, Jukema, JW & Tio, RA 2006, 'Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1.', Pharmacogenetics and genomics, vol. 16, no. 5, pp. 331-337.

Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1. / Wijpkema, J.S.; van Haelst, P.L.; Monraats, P.S. et al.
In: Pharmacogenetics and genomics, Vol. 16, No. 5, 2006, p. 331-337.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1.

AU - Wijpkema, J.S.

AU - van Haelst, P.L.

AU - Monraats, P.S.

AU - Bruinenberg, M.

AU - Zwinderman, A.H.

AU - Zijlstra, F.

AU - van der Steege, G.

AU - de Winter, R.J.

AU - Doevendans, P.A.F.M.

AU - Waltenberger, J.

AU - Jukema, J.W.

AU - Tio, R.A.

PY - 2006

Y1 - 2006

KW - Econometric and Statistical Methods: General

KW - Geneeskunde(GENK)

KW - Bescherming en bevordering van de menselijke gezondheid

KW - Other medical specialities

M3 - Article

SN - 1744-6872

VL - 16

SP - 331

EP - 337

JO - Pharmacogenetics and genomics

JF - Pharmacogenetics and genomics

IS - 5

ER -

Wijpkema JS, van Haelst PL, Monraats PS, Bruinenberg M, Zwinderman AH, Zijlstra F et al. Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1. Pharmacogenetics and genomics. 2006;16(5):331-337.